Different affinities of native α1B-adrenoceptors for ketanserin between intact tissue segments and membrane preparations

European Journal of Pharmacology

Volumn 584, Issue 2-3, 2008, Pages 222-228

  Sathi, Zakia Sultana ^a   Anisuzzaman, Abu Syed Md ^a   Morishima, Shigeru ^a   Suzuki, Fumiko ^a   Tanaka, Takashi ^a   Yoshiki, Hatsumi ^a   Muramatsu, Ikunobu ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

1B adrenoceptor; Assay conditions; Intact tissue segments; Ketanserin; Membranes

Indexed keywords

8 [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] 8 AZASPIRO[4.5]DECANE 7,9 DIONE; ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 1B ADRENERGIC RECEPTOR; ALPHA 1D ADRENERGIC RECEPTOR; KETANSERIN TARTRATE; PRAZOSIN; SILODOSIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BRAIN CORTEX; CONTROLLED STUDY; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; AORTA, THORACIC; ARTERIES; BINDING, COMPETITIVE; CELL LINE; CELL MEMBRANE; CEREBRAL CORTEX; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INDOLES; KETANSERIN; MALE; PIPERAZINES; PRAZOSIN; PROTEIN BINDING; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, ALPHA-1; RECOMBINANT PROTEINS; SUBCELLULAR FRACTIONS; TAIL; TRANSFECTION; VASOCONSTRICTION;

EID: 41349102130     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.02.003     Document Type: Article

References (40)

1. Arunlakushana O., and Schild H.O. Some quantitative uses of drug antagonists. Br. J. Pharmacol. Chemother. 14 (1959) 48-52
2. Bylund D.B., and Toews M.L. Radioligand binding methods: practical guide and tips. Am. J. Physiol. 265 (1993) L421-L429
3. 2 receptor blocking properties in blood vessels. J. Cardiovasc. Pharmacol. 11 (1988) S25-S29
4. Ford A.P., Arredondo N.F., Blue D.R., Bonhaus D.W., Jasper J., Kava M.S., Lesnick J., Pfister J.R., Shieh I.A., and Vimont R.L. RS-17053 (N-[2-(2-cyclopropylmethoxyphenoxy)ethyl]-5-chloro-alpha, alpha-dimethyl-1H-indole-3-ethanamine hydrochloride), a selective alpha 1A-adrenoceptor antagonist, displays low affinity for functional alpha1-adrenoceptors in human prostate: implications for adrenoceptor classification. Mol. Pharmacol. 49 (1996) 209-215
5. Frishman W.H., Huberfeld S., Okin S., Wang Y.H., Kumar A., and Shareef B. Serotonin and serotonin antagonism in cardiovascular and non cardiovascular diseases. J. Clin. Pharmacol. 35 (1995) 541-572
6. Furchgott R.F. The classification of adrenoceptors (adrenergic receptors). An evaluation from the stand point of receptor theory. In: Blaschko H., and Muscholl E. (Eds). Handbuch der Experimentellen Pharmacologie vol. 3 (1972) 283-335
7. Goetz A.S., King H.K., Ward S.D.C., True T.A., Rimele T.J., and Saussy D.L. BMY 7378 is a selective antagonist of the D subtype of alpha-1 adrenoceptors. Eur. J. Pharmacol. 272 (1995) R5-R6
8. Hanft G., and Gross G. Subclassification of α1-adrenoceptor recognition sites by urapidil derivatives and other selective antagonists. Br. J. Pharmacol. 97 (1989) 691-700
9. Hieble J.P., Bylund D.B., Clarke D.E., Eikenburg D.C., Langer S.Z., Lefkowitz R.J., Minneman K.P., and Ruffolo R.R. International Union of Pharmacology. X. Recommendation for nomenclature of alpha-1 adrenoceptors: consensus update. Pharmacol. Rev. 47 (1995) 267-270
10. Hiraizumi-Hiraoka Y., Tanaka T., Yamamoto H., Suzuki F., and Muramatsu I. Identification of α-1L adrenoceptor in rabbit ear artery. J. Pharmacol. Exp. Ther. 310 (2004) 995-1002
11. 1-adrenoceptor subtypes in the rat prostate. Eur. J. Pharmacol. 366 (1999) 119-126
12. 1B-adrenoceptors coexpressed in human embryonic kidney 293 cells. J. Pharmacol. Exp. Ther. 309 (2004) 259-266
13. Kalkman H.O., Timmermans P.B., and Van Zwieten P.A. Characterization of the antihypertensive properties of ketanserin (R 41 468) in rats. J. Pharmacol. Exp. Ther. 222 (1982) 227-231
14. Kenakin T. Ligand-selective receptor conformations revisited: the promise and the problem. Trends Pharmacol. Sci. Rev. 24 (2003) 346-354
15. 1A-adrenoceptor mediating contractile responses to noradrenaline in isolated caudal artery of rat. Br. J. Pharmacol. 120 (1997) 819-826
16. Maruyama K., Kinami J., Sugita Y., Takada Y., Sugiyama E., Tsuchihashi H., and Nagatomo T. MCI-9042: High affinity for serotonergic receptors assessed by radioligand binding assay. J. Pharmacobio-dyn. 14 (1991) 177-181
17. 1 adrenoceptor subtypes. Naunyn-Schmiedeberg's Arch. Pharmacol. 352 (1995) 1-10
18. Michelotti G.A., Price D.T., and Schwinn D.A. Alpha-1 adrenoceptor regulation: basic science and clinical implications. Pharmacol. Ther. 88 (2000) 281-309
19. 1-adrenergic receptor subtypes. Pharmacol. Toxicol. Annu. Rev. 34 (1994) 117-133
20. Morel N., and Godfraind T. Pharmacological properties of voltage-dependent calcium channels in functional microvessels isolated from rat brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 340 (1989) 442-451
21. Morishima S., Tanaka T., Yamamoto H., Suzuki F., and Muramatsu I. Identification of α -1L and α -1A adrenoceptors in human prostate by tissue segment binding. J. Urol. 177 (2007) 1-5
22. 3H]-prazosin binding. Mol. Pharmacol. 29 (1986) 321-326
23. Muramatsu I., Taki N., Zhang L., Israilova M., Hiraizumi Y., Morishima S., Suzuki F., and Tanaka T. Reserpine-induced supersensitivity and adrenoceptor alpha 1-subtypes. Nippon Yakurigaku Zasshi 122 (2003) 60-62
24. Muramatsu I., Tanaka T., Suzuki F., Zhang L., Hiraizumi-Hiraoka Y., Anisuzzaman A.S.M., Yamamoto H., Horinouchi T., and Morishima S. Tissue segment binding method - a powerful tool for pharmacome analysis of native receptors. J. Pharmacol. Sci. 98 (2005) 331-339
25. Murata S., Taniguchi T., and Muramatsu I. Pharmacological analysis of the novel, selective alpha1-adrenoceptor antagonist, KMD-3213 and its suitability as a tritiated radioligand. Br. J. Pharmacol. 127 (1999) 19-26
26. Murata S., Taniguchi T., Takahashi M., Okada K., Akiyama K., and Muramatsu I. Tissue selectivity of KMD-3213, an alpha (1)-adrenoreceptor antagonist, in human prostate and vasculature. J. Urol. 164 (2000) 578-583
27. Nelson C.P., and Challiss R.A.J. "Phenotypic" pharmacology: the influence of cellular environment on G protein-coupled receptor antagonist and inverse agonist pharmacology. Biochem. Pharmacol. 73 (2007) 737-751
28. Persson B., Gradin K., Petterson A., and Hedner T. Antihypertensive effects of ketanserin and ritanserin in the spontaneously hypertensive rat. J. Cardiovasc. Pharmacol. 11 (1988) S22-S24
29. 1-adrenergic receptors by vessel bed and age. Circulation 100 (1999) 2336-2343
30. Sayet I., Neuilly G., Rakotoarisoa L., Mironneau C., and Mironneau J. Relation between alpha 1-adrenoceptor subtypes and noradrenaline-induced contraction in rat portal vein smooth muscle. Br. J. Pharmacol. 110 (1993) 207-212
31. Scatchard G. The attractions of proteins for small molecules and ions. Ann. N.Y. Acad. Sci. 51 (1949) 660-672
32. 1B-adrenoceptor antagonist, (+)-cyclazosin. Eur. J. Pharmacol. 361 (1998) 79-83
33. Stassen F.R.M., Mass R.G.H.T., Schiffers P.M.H., Janssen G.M.J., and Demey J.G.R. A positive and reversible relationship between adrenergic nerves and alpha-1A adrenoceptors in rat arteries. J. Pharmacol. Exp. Ther. 284 (1998) 399-405
34. 1-adrenoceptor antagonist binding to recombinant human α1-adrenoceptors and human prostates. Life Sci. 67 (2000) 2443-2451
35. Taki N., Tanaka T., Zhang L., Suzuki F., Israilova M., Taniguchi T., Hiraizumi- Hiraoka Y., Shinozuka K., Kunitomo M., and Muramatsu I. Alpha-1D adrenoceptors are involved in reserpine-induced supersensitivity of rat tail artery. Br. J. Pharmacol. 142 (2004) 647-656
36. Tanaka T., Zhang L., Suzuki F., and Muramatsu I. Alpha-1 adrenoceptors: evaluation of receptor subtype binding-kinetics in intact arterial tissues and comparison with membrane binding. Br. J. Pharmacol. 141 (2004) 468-476
37. van Zwieten P.A., Blauw G.J., and van Brummelen P.P. Pharmacological profile of antihypertensive drugs with serotonin receptor and alpha -adrenoceptor activity. Drugs 40 (1990) 1-8
38. Vanhoutte P.M., Amery A., and Birkenhager W. Serotonergic mechanism in hypertension: Focus on the effects of ketanserin. Hypertension 11 (1988) 111-133
39. Yang M., Verfurth F., Buscher R., and Michel M.C. Is alpha-1D-adrenoceptor protein detectable in rat tissues? Naunyn Schmiedeberg Arch. Pharmacol. 335 (1997) 438-446
40. Zhong H., and Minneman K.P. Alpha-1 adrenoceptor subtypes. Eur. J. Pharmacol. 37 (1999) 261-276